非洲猪瘟病毒P72蛋白合成肽疫苗的构建及其免疫效力评估

doi:10.16431/j.cnki.1671-7236.2022.08.024

摘要/Abstract

摘要： 【目的】构建非洲猪瘟病毒CAS19-01/2019株(GenBank登录号:MN172368.1)结构蛋白P72的合成肽疫苗,通过免疫小鼠评估合成肽疫苗的免疫效力。【方法】利用ProtParam、SOPMA等软件分析P72蛋白的理化性质与结构信息,通过ABCpred、SVMtrip、IEDB预测P72蛋白的T细胞与B细胞抗原表位,筛选出显著的表位多肽区域,合成多肽辅以弗氏佐剂腹腔注射免疫小鼠,检测免疫组小鼠产生的特异性抗体、T淋巴细胞亚群、脾脏淋巴细胞增殖、细胞因子白介素4(IL-4)、IL-2、γ干扰素(IFN-γ)、免疫球蛋白(IgG),从体液免疫与细胞免疫角度评估合成肽的免疫效力。【结果】综合分析得出P72蛋白是稳定性亲水蛋白,二级结构中α-螺旋、β-转角、延伸链、无规则卷曲分别占19.35%、5.42%、25.08%和50.15%。筛选出了P72蛋白的8个优势抗原表位,626－634、520－528、298－306、203－211位氨基酸处为T细胞抗原表位,587－606、232－251、110－129、39－58位氨基酸处为B细胞抗原表位。整合优势表位合成2个多肽P72-1与P72-2,首次免疫小鼠14 d时可检测到P72-1与P72-2的特异性抗体,首免后28 d达到最高值,其最高抗体效价分别为1∶25 600与1∶12 800;免疫后小鼠T淋巴细胞亚群CD4^＋/CD8^＋显著上升(P＜0.05);脾脏淋巴细胞增殖试验结果显示,免疫组淋巴细胞数量均极显著升高(P＜0.01);细胞因子IL-4、IL-2、IFN-γ含量均极显著增加(P＜0.01)。【结论】本研究成功研制2种合成肽疫苗,在免疫效力上P72-2高于P72-1,二者都能产生高水平的特异性抗体,刺激脾脏淋巴细胞增殖,诱导产生细胞因子IL-4、IL-2、IFN-γ,本研究为非洲猪瘟合成肽疫苗研制奠定技术基础。

关键词: 非洲猪瘟病毒(ASFV); P72蛋白; 抗原表位; 合成肽疫苗

Abstract: 【Objective】 The aim of this study was to construct a synthetic peptide vaccine based on protein P72 in African swine fever virus (ASFV) strain CAS19-01/2019(GenBank accession No.:MIN172368.1),and evaluate its immune efficiency by immunizing mice.【Method】 The physicochemical properties and structural information of P72 protein were analyzed by programs of ProtParam and SOPMA.The significant epitopes in T and B lymphocytes were screened by ABCpred,SVMtrip and IEDCB.The synthesized peptides were injected intramuscularly into mice with Freund's adjuvant.Antibodies against the synthesized peptides,T lymphocyte subsets,lymphocyte proliferation,cytokines contents of interleukin 4(IL-4),IL-2,interferon-γ (IFN-γ) and immunoglobulin (IgG) were detected using serum and other tissue from the immunized mice,and the immune efficacy of the synthetic peptide was evaluated from the perspectives of humoral immunity and cellular immunity.【Result】 Comprehensive analysis showed that P72 protein was a stable hydrophilic protein.In secondary structure,alpha helix,beta turn,extended strand and random coil accounted for 19.35%,5.42%,25.08% and 50.15%,respectively.Eight dominant epitopes of protein P72 were selected by comprehensive software analysis,including T cell epitopes 626-634,520-528,298-306,203-211 amino acids,and B cell epitopes 587-606,232-251,110-129,39-58 amino acids. Two peptides named P72-1 and P72-2 were synthesized by integrating the dominant epitopes together.The specific antibodies against the synthesized peptides P72-1 and P72-2 were determined in serum of mice after 14 days of the first immunization,reached the highest value on the 28th day after the first immunization,and highest antibody titers were 1:25 600 and 1:12 800,respectively.The value of CD4⁺/CD8⁺ of T lymphocyte subsets in immunized mice were significantly increased (P<0.05).The spleen lymphocyte proliferation test showed that the number of lymphocytes was enhanced in both groups (P<0.01).Cytokines contents of IL-4,IL-2 and IFN-γ were extremely significantly improved (P<0.01).【Conclusion】 In this study,two synthetic peptide vaccines were successfully developed.P72-2 was higher than P72-1 in immune efficacy,and both could produce high level of specific antibodies,stimulate the proliferation of lymphocytes,induce the production of cytokines IL-4,IL-2 and IFN-γ.This study laid a technical foundation for the development of African swine fever vaccine.

Key words: African swine fever virus (ASFV); P72 protein; antigen epitopes; synthetic peptide vaccine

中图分类号:

S852.65⁺1

徐娅玲, 张霁辉, 牛熙, 李升, 黄世会, 冉雪琴, 王嘉福. 非洲猪瘟病毒P72蛋白合成肽疫苗的构建及其免疫效力评估[J]. 中国畜牧兽医, 2022, 49(8): 3083-3090.

XU Yaling, ZHANG Jihui, NIU Xi, LI Sheng, HUANG Shihui, RAN Xueqin, WANG Jiafu. Construction of Synthetic Peptide Vaccine of African Classical Swine Fever Virus P72 Protein and Evaluation of Its Immune Efficacy[J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(8): 3083-3090.

参考文献

[1] WANG N,ZHAO D,WANG J,et al.Architecture of African swine fever virus and implications for viral assembly[J].Science,2019,366(6465):640-644.
[2] REVILLA Y,PÉREZ-NÑEZ D,RICHT J A.African swine fever virus biology and vaccine approaches[J].Advances in Virus Research,2018,100:41-74.
[3] 刘海余.浅谈非洲猪瘟[J].猪业科学,2018,35(10):127. LIU H Y.Discussion on African swine fever[J].Swine Industry Science,2018,35(10):127.(in Chinese)
[4] ATUHAIRE D K,AFAYOA M,OCHWO S,et al.Molecular characterization and phylogenetic study of African swine fever virus isolates from recent outbreaks in Uganda (2010-2013)[J].Virology Journal,2013,10:247.
[5] DIXON L K,STAHL K,JORI F,et al.African swine fever epidemiology and control[J].Annual Review of Animal Biosciences,2020,8:221-246.
[6] O'NEILL X,WHITE A,RUIZ-FONS F,et al.Modelling the transmission and persistence of African swine fever in wild boar in contrasting European scenarios[J].Scientific Reports,2020,10(1):5895.
[7] 王华,王君玮,徐天刚,等.非洲猪瘟的疫情分布和传播及其控制[J].中国兽医科学,201040(4):438-440. WANG H,WANG J W,XU T G,et al.Review on spread,transmission and control of African swine fever[J]. Chinese Veterinary Science,2010,40(4):438-440.(in Chinese)
[8] LIU L,WANG X,MAO R,et al.Research progress on live attenuated vaccine against African swine fever virus[J].Microbial Pathogenesis,2021,158:105024.
[9] SCADENA-FERNÁNDEZ E,SÁNCHEZ-VIZCAÍNO J M,VAN DEN BORN E,et al.High doses of inactivated African swine fever virus are safe,but do not confer protection against a virulent challenge[J].Vaccines,2021,9(3):242.
[10] WU K,LIU J,WANG L,et al.Current state of global African swine fever vaccine development under the prevalence and transmission of ASF in China[J].Vaccines,2020,8(3):531.
[11] WANG F,ZHANG H,HOU L,et al.Advance of African swine fever virus in recent years[J].Research in Veterinary Science,2021,136:535-539.
[12] LIM H X,LIM J,POH C L.Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine[J].Medical Microbiology and Immunology,2021,210(1):1-11.
[13] 高瞻,邵军军,常艳燕,等.非洲猪瘟病毒p72蛋白抗原表位预测分析及多表位疫苗的构建[J].中国兽医杂志,2020,56(1):13-17. GAO Z,SHAO J J,CHANG Y Y,et al.Epitope prediction analysis of African swine fever virus p72 protein and construction of multi-epitope vaccine[J].Chinese Journal of Veterinary Medicine,2020,56(1):13-17.(in Chinese)
[14] PHILLIPS M E.Epitope mapping of African swine fever virus p72 capsid protein using polyclonal.swine sera and monoclonal antibodies[D].Kansas:Kansas State University,2016.
[15] 郭晶,李重阳,孟庆玲,等.非洲猪瘟病毒多表位融合蛋白P72的构建、表达及免疫学特性研究[J].家畜生态学报,2019,40(6):60-65. GUO J,LI C Y,MENG Q L,et al.Research on construction,expression and immunological characteristics of multi-epitope fusion antigen P72 of African swine fever virus[J].Journal of Domestic Animal Ecology,2019,40(6):60-65.(in Chinese)
[16] GALINDO I,ALONSO C.African swine fever virus:A review[J].Viruses,2017,9(5):103.
[17] 刘雪婷,王召阳,鑫婷,等.非洲猪瘟病毒B438L蛋白的原核表达及其多克隆抗体的制备与鉴定[J].中国畜牧兽医,2021,48(3):991-1000. LIU X T,WANG Z Y,XIN T,et al.Prokaryotic expression and polyclonal antibodies preparation and identification of African swine fever virus B438L protein[J].China Animal Husbandry&Veterinary Medicine,2021,13(3):991-1000.(in Chinese)
[18] BORCA M V,IRUSTA P,CARRILLO C,et al.African swine fever virus structural protein p72 contains a conformational neutralizing epitope[J].Virology,1994,201(2):413-418.
[19] 谢灵志.表达ASFV保护性抗原重组腺病毒载体疫苗的初步研制[D].扬州:扬州大学,2019. XIE L Z.Preliminary study of recombinant adenoviral vector vaccine expressing ASFV protective antigen[D].Yangzhou:Yangzhou University,2019.(in Chinese)
[20] CHEN X,YANG J,JI Y,et al.Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice[J].Virologica Sinica,2016,31(2):150-159.
[21] GERSHONI J M,ROITBURD-BERMAN A,SIMAN-TOV D D,et al.Epitope mapping[J].BioDrugs,2007,21(3):145-156.
[22] 唐华.A型口蹄疫病毒AF72株合成肽疫苗的研究及其免疫效力的评估[D].北京:中国农业科学院,2013. TANG H.Study and immunity assessment of synthetic peptide vaccines against AF72 strain of Foot-and-mouth disease virus type A[D].Beijing:Chinese Academy of Agricultural Sciences,2013.(in Chinese)
[23] 陈俊伊.EV-D68 VP1亚单位疫苗和多肽疫苗的免疫原性及保护性研究[D].重庆:重庆医科大学,2020. CHEN J Y.Immunogenicity and protection of EV-D68 VP1 subunit vaccine and peptide vaccine[D].Chongqing:Chongqing Medical University,2020.(in Chinese)
[24] 闫宗斌,伍生军,杨静,等.猪附红细胞体eno基因重组蛋白的制备及免疫效果研究[J].中国畜牧兽医,2020,47(7):2231-2238. YAN Z B,WU S J,YANG J,et al.Preparation of recombinant protein of Mycoplasma suis eno gene and its immunity effect[J].China Animal Husbandry&Veterinary Medicine,2020,47(7):2231-2238.(in Chinese)
[25] 孟媛,曾嘉庆,于成东,等.塞尼卡病毒VP1蛋白亚单位候选疫苗小鼠免疫评价[J].中国兽医学报,2021,41(11):2085-2090. MENG Y,ZENG J Q,YU C D,et al.Immune evaluation of candidate Seneca virus VP1 protein subunit vaccine in mice[J].Chinese Journal of Veterinary,2021,41(11):2085-2090.(in Chinese)
[26] 魏冰.两种Th表位合成肽对O型口蹄疫病毒合成肽疫苗免疫增效作用的研究[D].天津:天津农学院,2016. WEI B.Study on synergistic effect of two Th epitopes synthetic peptides on O-type Foot-and-mouth disease virus synthetic peptide vaccine[D].Tianjin:Tianjin Agricultural University,2016.(in Chinese)